Chongqing Lummy Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 360.285 million compared to CNY 248.566 million a year ago. Operating income was CNY 63.012 million compared to operating loss of CNY 12.906 million a year ago. Net income was CNY 48.906 million compared to net loss of CNY 8.119 million a year ago. Basic earnings per share from continuing operations was CNY 0.0549 compared to basic loss per share from continuing operations of CNY 0.01 a year ago.